[SRNE] YoY Quarter Result on 31-Dec-2014 [#Q4]

Stock
[SRNE] Sorrento Therapeutics, Inc.
Announcement Date
13-Mar-2015
Financial Year
2014
Quarter
31-Dec-2014 [#Q4]
Profit Trend
QoQ- -11.83%
YoY- 24.71%
Quarter Report
SRNE's Result
SRNE's Financial Summary
View:
Show?
Quarter Result
31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 CAGR
Revenue 20,407 4,019 1,337 798 101 122 128 132.68%
PBT -38,001 -12,724 -25,413 -10,207 -11,296 -3,236 -3,236 50.70%
Tax -90,424 -701 1,186 1 4 -3,090 -2,474 82.07%
NP 12,425 -11,957 -23,476 -8,505 -11,296 -1,755 -762 -
Tax Rate - - - - - - - -
Total Cost 7,982 15,976 24,813 9,303 11,397 1,877 890 44.09%
Ratio Analysis
31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 CAGR
NP Margin 60.89 -297.51 -1,755.87 -1,065.79 -11,217.68 -1,438.58 -595.84 -
Per Share
31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 CAGR
EPS 0.15 -0.23 -0.62 -0.23 -0.49 -0.14 -0.07 -
EPS Diluted 0.15 -0.23 -0.62 -0.23 -0.49 -0.14 -0.07 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.